Orion Pharma Limited (DSE: ORIONPHARM)
Bangladesh
· Delayed Price · Currency is BDT 49.60
+2.10 (4.42%)
At close: Sep 12, 2024
Orion Pharma Ratios and Metrics
Market cap in millions BDT. Fiscal year is July - June.
Millions BDT. Fiscal year is Jul - Jun.
Fiscal Year | Current | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | 2018 - 2014 |
|---|---|---|---|---|---|---|---|
Period Ending | Sep '24 Sep 11, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 | Jun '21 Jun 30, 2021 | Jun '20 Jun 30, 2020 | Jun '19 Jun 30, 2019 | 2018 - 2014 |
| Market Capitalization | 11,606 | 18,626 | 20,592 | 12,613 | 9,828 | 7,769 | Upgrade
|
| Market Cap Growth | -10.43% | -9.55% | 63.27% | 28.33% | 26.51% | -19.81% | Upgrade
|
| Enterprise Value | 35,202 | 42,351 | 40,514 | 28,904 | 23,780 | 16,803 | Upgrade
|
| Last Close Price | 49.60 | 78.60 | 85.90 | 51.99 | 39.57 | 29.78 | Upgrade
|
| PE Ratio | 25.48 | 28.70 | 23.76 | 12.96 | 13.91 | 7.90 | Upgrade
|
| PS Ratio | 1.01 | 1.34 | 2.13 | 1.16 | 1.29 | 0.89 | Upgrade
|
| PB Ratio | 0.53 | 0.83 | 0.99 | 0.63 | 0.51 | 0.41 | Upgrade
|
| P/FCF Ratio | -13.66 | -13.63 | -13.68 | -7.48 | 29.00 | 77.62 | Upgrade
|
| P/OCF Ratio | 10.33 | 7.47 | 17.72 | 4.87 | 5.22 | 5.36 | Upgrade
|
| EV/Sales Ratio | 3.06 | 3.04 | 4.19 | 2.67 | 3.11 | 1.93 | Upgrade
|
| EV/EBITDA Ratio | 29.14 | 26.52 | 34.86 | 11.43 | 9.66 | 6.98 | Upgrade
|
| EV/EBIT Ratio | 50.63 | 41.69 | 58.77 | 18.79 | 15.32 | 10.60 | Upgrade
|
| EV/FCF Ratio | -28.82 | -31.00 | -26.92 | -17.15 | 70.17 | 167.88 | Upgrade
|
| Debt / Equity Ratio | 0.96 | 0.98 | 0.90 | 0.84 | 0.72 | 0.47 | Upgrade
|
| Debt / EBITDA Ratio | 18.64 | 13.54 | 15.68 | 6.59 | 5.51 | 3.62 | Upgrade
|
| Debt / FCF Ratio | -18.30 | -16.03 | -12.37 | -9.99 | 40.50 | 87.12 | Upgrade
|
| Asset Turnover | 0.22 | 0.28 | 0.21 | 0.27 | 0.23 | 0.28 | Upgrade
|
| Inventory Turnover | 4.39 | 7.12 | 5.01 | 6.10 | 4.62 | 5.85 | Upgrade
|
| Quick Ratio | 1.46 | 1.64 | 1.59 | 2.14 | 2.86 | 2.50 | Upgrade
|
| Current Ratio | 1.86 | 2.01 | 1.99 | 2.70 | 3.99 | 3.00 | Upgrade
|
| Return on Equity (ROE) | 2.01% | 3.22% | 4.36% | 5.73% | 3.89% | 5.27% | Upgrade
|
| Return on Assets (ROA) | 0.81% | 1.26% | 0.95% | 2.43% | 2.86% | 3.21% | Upgrade
|
| Return on Capital (ROIC) | 0.95% | 1.52% | 1.13% | 2.75% | 3.21% | 3.71% | Upgrade
|
| Earnings Yield | 3.92% | 3.44% | 4.11% | 7.45% | 6.77% | 11.36% | Upgrade
|
| FCF Yield | -10.52% | -7.34% | -7.31% | -13.36% | 3.45% | 1.29% | Upgrade
|
| Dividend Yield | 2.02% | 1.27% | 1.16% | 2.31% | 2.53% | 5.04% | Upgrade
|
| Payout Ratio | 23.81% | 23.86% | 38.36% | 36.22% | 56.04% | 38.10% | Upgrade
|
| Total Shareholder Return | 2.02% | 1.27% | 1.16% | 2.31% | 2.53% | 5.04% | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.